GlaxoSmithKline Pharmaceuticals Limited has announced the receipt of a tax refund amounting to ₹4.99 Crore for the Assessment Year (AY) 2025-2026. The company was intimated about this refund via Section 143(1) of the Income Tax Act. The refund was credited to the bank account on August 18, 2026, following the intimation received on August 19, 2026. This refund will be accounted for in the Tax Paid Assets account on the Balance Sheet.
Tax Refund Received
GlaxoSmithKline Pharmaceuticals Limited has officially disclosed the receipt of a significant tax refund. The company was notified of a refund totaling ₹4,99,11,100 (₹4.99 Crore) under Section 143(1) of the Income Tax Act for the Assessment Year (AY) 2025-2026. This intimation was received on August 19, 2026.
Financial Accounting
The refund was credited to the company’s bank account on August 18, 2026. The impact on the company’s financial operations is that this tax refund will be accounted for in the Tax Paid Assets account on the Balance Sheet. No violations or contraventions were alleged by the authority.
Source: BSE
